{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0074-2600",
      "generic_name": "Glecaprevir and Pibrentasvir",
      "labeler_name": "AbbVie Inc.",
      "brand_name": "Mavyret",
      "active_ingredients": [
        {
          "name": "PIBRENTASVIR",
          "strength": "20 mg/1"
        },
        {
          "name": "GLECAPREVIR",
          "strength": "50 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0074-2600-28",
          "description": "1 PACKET in 1 CARTON (0074-2600-28)  / 28 PELLET in 1 PACKET",
          "marketing_start_date": "20210622",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "AbbVie Inc."
        ],
        "rxcui": [
          "1940703",
          "1940709",
          "2557906",
          "2557910"
        ],
        "spl_set_id": [
          "7bf99777-0401-9095-8645-16c6e907fcc0"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000191256",
          "N0000185503",
          "N0000190113",
          "N0000190107",
          "N0000190108",
          "N0000190114",
          "N0000182138",
          "N0000191272",
          "N0000182639",
          "N0000182638"
        ],
        "pharm_class_epc": [
          "Hepatitis C Virus NS5A Inhibitor [EPC]",
          "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
          "Cytochrome P450 3A Inhibitors [MoA]",
          "Cytochrome P450 1A2 Inhibitors [MoA]",
          "UGT1A1 Inhibitors [MoA]",
          "HCV NS3/4A Protease Inhibitors [MoA]"
        ],
        "unii": [
          "2WU922TK3L",
          "K6BUU8J72P"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "PELLET",
      "spl_id": "c1aa97e0-7350-4286-ac17-915bcdf0b08a",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20210610",
      "product_id": "0074-2600_c1aa97e0-7350-4286-ac17-915bcdf0b08a",
      "application_number": "NDA215110",
      "brand_name_base": "Mavyret",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 1A2 Inhibitors [MoA]",
        "Cytochrome P450 1A2 Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "HCV NS3/4A Protease Inhibitors [MoA]",
        "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]",
        "Hepatitis C Virus NS5A Inhibitor [EPC]",
        "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
        "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
        "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
        "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "UGT1A1 Inhibitors [MoA]",
        "UGT1A1 Inhibitors [MoA]"
      ]
    }
  ]
}